hat
Andokrin efè segondè te note pandan exogenous administrasyon nan estewoyid anabolizan te enkli anpèchman nan testostewòn endogenous pa vle di nan anpèchman fidbak nan òmòn luteinizing pitimi (LH). Dòz Gwo estewoyid anabolizan anabolizan ka siprime spermatogenesis nan anpèchman nan òmòn pitwitèr stimulan òmòn (FSH). Aktivite Androjenik a nan estewoyid anabolizan yo ka diminye nivo globilin tiboksin-obligatwa ak rezilta diminye kantite total seran T4 ak ogmante absorption résine nan T3 ak T4. Gratis nivo òmòn tiwoyid rete san chanje epi pa gen okenn prèv klinik nan malfonksyònman tiwoyid.
eng
Endocrine side effects noted during exogenous administration of anabolic steroids have included inhibition of endogenous testosterone release by means of feedback inhibition of pituitary luteinizing hormone (LH). Large doses of exogenous anabolic steroids may suppress spermatogenesis through inhibition of pituitary follicle stimulating hormone (FSH). The androgenic activity of anabolic steroids may decrease levels of thyroxin-binding globulin and result in decreased total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged and there is no clinical evidence of thyroid dysfunction.